WAVE Clinical Platform vs PeraMobile and PeraWatch
AI Verdict
Choose WAVE Clinical Platform if…
Choose WAVE Clinical Platform if your primary need is continuous, real-time remote patient monitoring with advanced predictive analytics based on physiological data, including waveforms and alarms. This tool is ideal for hospitals seeking to proactively identify patient deterioration up to six hours in advance through an FDA-cleared AI system and customize alarm management workflows extensively.
View WAVE Clinical Platform →Choose PeraMobile and PeraWatch if…
Choose PeraMobile and PeraWatch if your organization prioritizes system-wide patient acuity scoring using the FDA-cleared Rothman Index to identify at-risk patients and enable mobile access for clinicians. This solution is well-suited for improving overall quality and reducing costs through real-time patient condition trends and retrospective analytics for continuous quality improvement initiatives.
View PeraMobile and PeraWatch →When choosing between WAVE Clinical Platform and PeraMobile/PeraWatch, physicians should consider their primary need for real-time surveillance versus broader predictive analytics. WAVE Clinical Platform excels in continuous, near real-time remote patient monitoring, offering predictive analytics for early warning of deterioration up to six hours in advance, along with customizable alarm management. It’s best suited for environments requiring constant vigilance over individual patients, such as critical care or emergency medicine, where immediate intervention based on physiological data and waveforms is paramount.
In contrast, PeraMobile and PeraWatch, powered by the Rothman Index, focus on real-time patient acuity scoring and system-wide virtual surveillance. While also providing predictive analytics for patient deterioration, its strength lies in offering a comprehensive view of patient condition trends and retrospective analytics for quality improvement. This makes it ideal for physicians and healthcare systems looking to identify at-risk patients across a broader population, improve overall quality metrics, and integrate seamlessly with existing EHRs for a more holistic data-driven approach.
The key practical difference lies in their data presentation and focus: WAVE emphasizes granular, real-time physiological data and waveforms for immediate clinical decision support, while PeraHealth prioritizes an acuity score (Rothman Index) for broader risk stratification and population health insights. Physicians prioritizing continuous, detailed physiological monitoring and customizable alarms for individual patient safety will likely prefer WAVE. Those seeking a system-wide view of patient acuity, predictive insights for earlier intervention across a larger patient base, and tools for quality improvement will find PeraMobile/PeraWatch more aligned with their needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | WAVE Clinical Platform | PeraMobile and PeraWatch |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Software platform, leverages existing hospital IT infrastructure, client-server architecture, web-enabled devices. | Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
WAVE Clinical PlatformTool A, the WAVE Clinical Platform, offers a comprehensive and adaptable user experience by displaying detailed physiological data, waveforms, and alarms across hospital workstations, mobile devices, and EMRs. Its customizable alarm management and routing (AlarmNavigator) further enhance usability by tailoring alerts and reducing fatigue. While Tool B provides good mobile and dashboard features, Tool A's rich data visualization and advanced alarm management capabilities appear to cater to a wider range of clinical needs more extensively.
Clinical Value
PeraMobile and PeraWatchWhile Tool A is notable as the 'first FDA-cleared AI patient surveillance system' and demonstrated a significant reduction in unexpected deaths in one study, Tool B's Rothman Index offers a more comprehensive and general measure of patient condition. It integrates a broader range of clinical inputs, including nursing assessments and labs, providing a holistic view of patient acuity. Multiple clinical trials have consistently shown a 30% reduction in hospital mortality with the Rothman Index.
Pricing & Value
TieBoth tools explicitly state 'Contact for pricing' and are positioned as enterprise-level solutions, indicating a lack of public pricing transparency. Without specific pricing models, detailed ROI metrics, or publicly available information on contract terms, it is not possible to definitively determine which tool offers superior value.
Enterprise Readiness
PeraMobile and PeraWatchBoth tools offer robust EMR/EHR integration and mobile capabilities essential for enterprise deployment. However, Tool B's explicit mention of 'System-wide virtual surveillance (PeraWatch)' and 'Retrospective analytics for quality improvement (PeraAnalytics)' suggests a more comprehensive suite for enterprise-wide management, strategic analysis, and long-term operational efficiency. Tool A, while strong in integration and vendor-agnostic data capture, does not detail these broader analytical and surveillance capabilities as extensively.
Innovation
PeraMobile and PeraWatchWhile Tool A holds the distinction of being the 'first FDA-cleared AI patient surveillance system,' Tool B's Rothman Index represents a deeper innovation in its methodology. It integrates a comprehensive set of clinical inputs, including often-overlooked nursing assessments, to create a 'universal patient score' that detects subtle deterioration, addressing a critical gap in traditional vital-sign-based systems. This holistic approach to patient acuity scoring is a more fundamental innovation.
Support & Docs
PeraMobile and PeraWatchSpacelabs Healthcare, the parent company of PeraHealth (Tool B), clearly outlines comprehensive support services, including 24/7 technical support, regular training courses, and definitive technical documentation. While Tool A's parent company (Baxter/Hillrom) likely offers support and implies documentation availability, the public information is less explicit and detailed regarding specific support channels, hours, and documentation resources compared to Tool B.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | WAVE Clinical Platform | PeraMobile and PeraWatch |
|---|---|---|
| Product Name | WAVE Clinical Platform | PeraMobile and PeraWatch |
| Company | Excel Medical Electronics | PeraHealth (acquired by Spacelabs Healthcare) |
| Core Predictive Technology | Predictive algorithms (e.g., Visensia Safety Index) | Rothman Index |
| EMR/EHR Integration | Integration with Electronic Medical Records (EMR) | Integration with major EHR vendors |
| Mobile Access | Mobile device compatibility for alerts and data display | Mobile access for on-the-go clinicians (PeraMobile) |
| Early Warning Capability | Early warning of patient deterioration (up to 6 hours in advance) | Identify at-risk patients sooner for earlier intervention |
Videos
Demos, reviews, and walkthroughs featuring WAVE Clinical Platform and PeraMobile and PeraWatch.